Dilaforette has received SEK2.85m ($425m) to develop sevuparin, a new treatment for severe malaria from Vinnova, a Swedish Governmental Agency. Sevuparin is an adjunctive therapy to anti-parasite medicines to prevent the infected red ...
Tags: Dilaforette, sevuparin, severe malaria